6-methylsulfinylhexyl Isothiocyanate

2 trials

Sponsors

Department of Pediatrics,Kobe University Graduate School of Medicine, Kobe University

Conditions

Duchenne muscular dystrophy

Phase 1

Open label, safty study of 6-methylsulfinylhexyl Isothiocyanate(6-MSITC) to Duchenne muscular dystrophy

Active, not recruitingJPRN-UMIN000027825

Department of Pediatrics,Kobe University Graduate School of MedicineDuchenne muscular dystrophy

Start: 2016-12-01Target: 6Updated: 2026-06-29

Open label, efficacy and safety study of long-term 6-methylsulfinylhexyl Isothiocyanate(6-MSITC) administration to Duchenne muscular dystrophy

Active, not recruitingJPRN-UMIN000033016

Kobe UniversityDuchenne muscular dystrophy

Start: 2018-08-01Target: 3Updated: 2026-06-29